Internal Medicine, Hematology & Oncology · Lake Worth, FL
NPI
1891749164
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3450 Lantana Rd, Suite 100
Lake Worth, FL, 33462
Phone (561) 965-1864
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
140,424 services
Medicare patients, 2024
433
Average age 74
Drug cost, 2024
$8.2M
2,298 prescriptions
Company payments, 2025
$16K
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Humberto J Caldera was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 17,000 times for 12 patients. In total Humberto J Caldera billed 140,424 services in 138 codes, and Medicare paid $2.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-04.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 17,000 | 12 | $2.30 | $39K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,262 | 27 | $0.09 | $200 |
| 85025 Blood Count | Office | 1,314 | 313 | $7.57 | $9,946 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,080 | 16 | $0.07 | $75.82 |
| 36415 Venipuncture Blood Collection | Office | 1,038 | 299 | $8.65 | $8,979 |
| 80053 Clinical Chemistry | Office | 967 | 296 | $10.35 | $10K |
| 99214 Office E&M - Established | Office | 732 | 279 | $98.72 | $72K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 683 | 63 | $0.51 | $348 |
| 96367 Intravenous Infusion, Hydration | Office | 381 | 38 | $21.96 | $8,368 |
| 96372 Injection Administration | Office | 329 | 38 | $11.40 | $3,750 |
| 96413 Chemotherapy Administration | Office | 280 | 40 | $102.26 | $29K |
| 82378 Clinical Chemistry | Office | 220 | 106 | $18.58 | $4,088 |
| 84466 Clinical Chemistry | Office | 184 | 92 | $12.50 | $2,300 |
| 83540 Clinical Chemistry | Office | 183 | 92 | $6.34 | $1,160 |
| 82728 Clinical Chemistry | Office | 182 | 91 | $13.36 | $2,432 |
By year: 2022 $2.3M for 137,590 services; 2023 $2.5M for 144,568 services; 2024 $2.5M for 140,424 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,314 | 313 | $7.57 | $9,946 |
| 36415 Venipuncture Blood Collection | 1,038 | 299 | $8.65 | $8,979 |
| 80053 Clinical Chemistry | 967 | 296 | $10.35 | $10K |
| 82378 Clinical Chemistry | 220 | 106 | $18.58 | $4,088 |
| 84466 Clinical Chemistry | 184 | 92 | $12.50 | $2,300 |
| 83540 Clinical Chemistry | 183 | 92 | $6.34 | $1,160 |
| 82728 Clinical Chemistry | 182 | 91 | $13.36 | $2,432 |
| 83615 Clinical Chemistry | 164 | 93 | $5.92 | $971 |
| 82607 Clinical Chemistry | 61 | 51 | $14.78 | $902 |
| 82746 Clinical Chemistry | 50 | 45 | $14.41 | $721 |
Medicare prescription drug claims, 2024
In 2024, the drug Humberto J Caldera prescribed most often to Medicare patients was Anastrozole, with 222 prescriptions and refills. In total Humberto J Caldera wrote 2,298 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 222 | 607 | 67 | $3,689 |
| Eliquis Apixaban | 155 | 167 | 25 | $96K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 89 | 89 | 33 | $2,860 |
| Dexamethasone Generic | 88 | 113 | 32 | $2,600 |
| Tamoxifen Citrate Generic | 88 | 243 | 25 | $2,048 |
| Ondansetron Hcl Generic | 84 | 84 | 52 | $729 |
| Abiraterone Acetate Generic | 78 | 80 | 12 | $141K |
| Oxycodone Hcl Generic | 75 | 75 | 16 | $2,282 |
| Lenalidomide Generic | 74 | 74 | 11 | $1.0M |
| Letrozole Generic | 74 | 212 | 22 | $1,543 |
| Megestrol Acetate Generic | 61 | 63 | 23 | $4,001 |
| Alprazolam Generic | 53 | 53 | 19 | $185 |
| Ondansetron Odt Ondansetron | 51 | 51 | 24 | $793 |
| Temazepam Generic | 50 | 50 | Under 11 | $382 |
| Xarelto Rivaroxaban | 47 | 67 | Under 11 | $36K |
Brand drugs: 611 claims; generic drugs: 1,687 claims; opioid claims: 284.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Humberto J Caldera $16K ($16K in general payments such as food, travel and fees) from 46 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $6,832.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $6,832 |
| BeiGene USA, Inc. ONC | 5 | $3,320 |
| Janssen Biotech, Inc. JNJ | 23 | $2,117 |
| Pfizer Inc. PFE | 19 | $340 |
| Genzyme Corporation SNY | 11 | $271 |
| Celgene Corporation BMY | 11 | $230 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $217 |
| Genentech USA, Inc. ROG.SW | 7 | $177 |
| Daiichi Sankyo Inc. 4568.T | 8 | $159 |
| Novocure Inc. NVCR | 1 | $152 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.